During his recent appearance on CNBC’s ‘Halftime Report’ on March 4, 2024, Jim Lebenthal, the chief equity strategist at Cerity Partners, surprised viewers by revealing that he had decided to sell his shares in Thermo Fisher Scientific. This unexpected move caught the attention of market watchers, who were eager to hear Lebenthal’s rationale for parting ways with the stock. Lebenthal’s decision to sell Thermo Fisher Scientific was seen as a significant development in the market, sparking speculation about the potential impact on the company’s stock price.
Thermo Fisher Scientific Inc. (TMO) Stock Performance Review – March 4, 2024
On March 4, 2024, Thermo Fisher Scientific Inc. (TMO) had a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, TMO showed signs of positive momentum. The price of TMO shares increased by $5.38 since the market last closed, representing a 0.93% rise. The stock opened at $576.55, which was $0.22 higher than its previous close. Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, reagents, consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The positive performance of TMO on March 4, 2024, may be attributed to various factors, including strong financial results, positive industry trends, and overall market sentiment. It is important for investors to conduct their own research and analysis before making investment decisions. Consult with a financial advisor or investment professional to determine the best course of action for your individual investment goals and risk tolerance.
Thermo Fisher Scientific Inc. (TMO) Stock Performance Analysis: Revenue, Net Income, and EPS Trends – March 4, 2024
On March 4, 2024, Thermo Fisher Scientific Inc. (TMO) stock performance was closely watched by investors and analysts. The company’s total revenue for the past year was reported at $42.86 billion, with a quarterly total revenue of $10.89 billion. This represented a 4.58% decrease in total revenue since the previous year, but the revenue held flat compared to the previous quarter.
Similarly, Thermo Fisher’s net income for the past year was $6.00 billion, with a quarterly net income of $1.63 billion. The net income decreased by 13.74% since the previous year and by 4.96% since the previous quarter.
Earnings per share (EPS) for Thermo Fisher stood at $15.45 for the past year and $4.20 for the quarter. This represented a 12.41% decrease in EPS since the previous year, but the EPS held flat compared to the previous quarter.
The stock performance of TMO on March 4, 2024, reflected these financial results. Investors may have been concerned about the decrease in total revenue, net income, and EPS compared to the previous year. However, the fact that these metrics held flat compared to the previous quarter may have provided some stability and reassurance to investors.
Overall, while the financial results for Thermo Fisher showed a decline in performance compared to the previous year, the fact that the results were consistent with the previous quarter may indicate that the company is stabilizing. Investors will continue to monitor TMO’s performance closely to assess its future growth prospects and potential for stock price appreciation.
